A Tata Trusts initiative, India Health Fund (IHF) has funded two platforms that are developed to help diagnose multiple diseases. The first innovation developed by Ameliorate Biotech is a fever panel to detect dengue, chikungunya, and malaria, which is a 15-minute test using a single test kit and a single blood sample, eliminating the need of serum/plasma samples and cold chain facility/biosafety lab. The 12-month funding from IHF will enable prospective, multicentric performance and cost-effectiveness evaluation of the RDT at a discounted price of ₹200 per piece for government procurements. The other platform developed by Medprime Technologies involves an artificial intelligence-powered software for faster and cost-effective detection and differentiation between malarial parasites.
Tata Trusts Initiative Funds Two Platforms to Aid in Disease Diagnosis
A Tata Trusts initiative, India Health Fund (IHF) has funded two platforms that are developed to help diagnose multiple diseases. The first innovation developed by Ameliorate Biotech is a fever panel to detect dengue, chikungunya, and malaria; and the other by Medprime Technologies, is a microscope-agnostic Artificial Intelligence (AI)-enabled diagnosis software.
Latest from Blog
Manu Chopra, CEO of Karya Inc., emphasized the importance of utilizing artificial intelligence (AI) to reduce
Italy has decided to withdraw from China's Belt and Road Initiative, becoming the only G7 nation
Zerodha's top executives collectively received a remuneration of about ₹200 crore in the financial year 2022-23,
New research suggests that radiotherapy may not be necessary for many patients with ductal carcinoma in
The US Space Force's X-37B space plane is gearing up for its seventh mission, after landing
